RPRX ææ°ååæã®æ±ºç®å ±åæž
çºè¡šæ¥8/5/2026
EPSå®çžŸïŒUSDïŒ0.04
売äžé«å®çžŸïŒUSDïŒ674.14M
Royalty Pharma PLCã®æ±ºç®æ¥ã»å ±åæž
ãã®ããŒãžã§ã¯ãææ°ã® Royalty Pharma PLC ã®æ±ºç®å ±åæžã次å Royalty Pharma PLC ã®æ±ºç®äºå®æ¥ãéå»ã®ããŒã¿ãRoyalty Pharma PLC ã®æ±ºç®é»è©±äŒè°ãã¥ãŒã¹ãªã©ã詳现㪠Royalty Pharma PLC ã®æ±ºç®ããŒã¿ãæäŸããŠããŸãã
RPRX 次åååæã®æ±ºç®çºè¡šæ¥
çºè¡šæ¥--
EPSäºæ³ïŒUSDïŒ--
売äžé«äºæ³ïŒUSDïŒ--
RPRX FY2025 決ç®
EPS (å幎åææ¯)1.79-6.41%
売äžé« (å幎åææ¯)2.38B5.06%
Royalty Pharma PLCïŒRPRXïŒã®æ±ºç®å±¥æŽ
| å ¬éæ¥ | 察象æéçµäº | EPS/äºæž¬ | åç/äºæž¬ | EPSãµãã©ã€ãº % | 売äžé«ãµãã©ã€ãº % |
|---|---|---|---|---|---|
| 8/5/2026 | 06/2026 | 0.04/1.28 | 674.14M/693.19M | -96.85% | -2.75% |
| 5/6/2026 | 03/2026 | 0.67/1.21 | 630.58M/1.24B | -44.36% | -48.95% |
| 2/11/2026 | 12/2025 | 0.50/1.33 | 621.99M/795.92M | -62.29% | -21.85% |
| 11/5/2025 | 09/2025 | 0.67/1.04 | 609.29M/739.26M | -36.01% | -17.58% |
| 8/6/2025 | 06/2025 | 0.07/1.08 | 578.66M/684.05M | -93.43% | -15.41% |
| 5/8/2025 | 03/2025 | 0.55/1.59 | 568.25M/750.46M | -65.56% | -24.28% |
| 2/11/2025 | 12/2024 | 0.47/1.05 | 593.64M/678.89M | -55.69% | -12.56% |
| 11/6/2024 | 09/2024 | 1.22/0.93 | 564.69M/696.10M | 30.90% | -18.88% |